Company Filing History:
3 out of 18 
1 out of 8 
1 out of 5 Years Active: 2023-2024
Title: Innovations by Inventor Yunying Chen in Antibody Development
Introduction: Yunying Chen, an esteemed inventor based in Shanghai, China, has made significant contributions to the field of biotechnology with a focus on antibody development. With three patents to his name, his work has advanced the understanding and application of antibodies in medical treatments.
Latest Patents: Among his notable patents, the "Anti-PD-1 antibodies" invention showcases novel antibodies that specifically target the cell surface protein PD-1. This invention includes not only the antibodies themselves but also the nucleic acid molecules encoding them, along with expression vectors and host cells utilized for their expression. Furthermore, the methods for producing these antibodies and their uses are elaborated upon within the patent. Another remarkable patent is the "Anti-EGFR antibody polypeptide," which covers antibody polypeptides against EGFR, their encoding polynucleotides, pharmaceutical compositions, and their applications in medical therapies.
Career Highlights: Yunying Chen has dedicated portions of his career to working with reputable companies in the biotechnology industry. Notably, he has been affiliated with Wuxi Biologics Ireland Limited, where he contributed to innovative developments in biologic therapies, and CStone Pharmaceuticals, focusing on precision medicine solutions targeting cancer.
Collaborations: Throughout his career, Yunying Chen has collaborated with talented professionals, including Jing Li, who has been an integral part of his team. Their combined efforts have driven innovative research and development initiatives aimed at enhancing therapeutic outcomes in patients.
Conclusion: With his significant contributions to patentable inventions in antibody technology, Yunying Chen stands as an influential figure in biotechnology. His work continues to inspire further research and innovations in the field, showcasing the potential of targeted therapies for various medical conditions.